Research Article
Open Access
New botulinum neurotoxin constructs for treatment of chronic pain
View ORCID ProfileCharlotte Leese, View ORCID ProfileClaire Christmas, View ORCID ProfileJudit Mészáros, Stephanie Ward, View ORCID ProfileMaria Maiaru, Stephen P Hunt, View ORCID ProfileBazbek Davletov Correspondence email
Charlotte Leese
1Department of Biomedical Science, University of Sheffield, Sheffield, UK
Roles: Investigation, Methodology, Writing—review and editing
Claire Christmas
1Department of Biomedical Science, University of Sheffield, Sheffield, UK
Roles: Conceptualization, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing
Judit Mészáros
1Department of Biomedical Science, University of Sheffield, Sheffield, UK
Roles: Investigation, Visualization, Methodology
Stephanie Ward
1Department of Biomedical Science, University of Sheffield, Sheffield, UK
Roles: Investigation
Maria Maiaru
3Department of Pharmacology, School of Pharmacy, University of Reading, Whiteknights Campus, Reading, UK
Roles: Investigation, Methodology
Stephen P Hunt
2Cell and Developmental Biology, University College London, London, UK
Roles: Conceptualization, Supervision, Funding acquisition, Project administration, Writing—review and editing
Bazbek Davletov
1Department of Biomedical Science, University of Sheffield, Sheffield, UK
4Neuresta, Inc., San Diego, CA, USA
Roles: Conceptualization, Supervision, Funding acquisition, Writing—original draft, Project administration, Writing—review and editing
Published 11 April 2023. DOI: 10.26508/lsa.202201631
New botulinum constructs for pain relief
Charlotte Leese, Claire Christmas, Judit Mészáros, Stephanie Ward, Maria Maiaru, Stephen P Hunt, Bazbek Davletov
Life Science Alliance Apr 2023, 6 (6) e202201631; DOI: 10.26508/lsa.202201631
In this Issue
Volume 6, No. 6
June 2023
Advertisement
Jump to section
Subjects
Related Articles
- No related articles found.
Cited By...
- No citing articles found.